Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Yumanity Therapeutics Q2 EPS $(0.45) Up From $(1.03) YoY

Author: Benzinga Newsdesk | August 04, 2022 06:25pm
Yumanity Therapeutics (NASDAQ:YMTX) reported quarterly losses of $(0.45) per share. This is a 56.31 percent increase over losses of $(1.03) per share from the same period last year.

Posted In: YMTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist